HRTX - Heron Therapeutics announces acceptance of PAS application for dual-acting anesthetic July, 02 2024 09:18 AM Heron Therapeutics Inc. 2024-07-02 09:18:19 ET More on Heron Therapeutics Heron Therapeutics: Opioid-Free Surgical Pain Relief Maven With Low Cash Reserves Seeking Alpha’s Quant Rating on Heron Therapeutics Historical earnings data for Heron Therapeutics For further details see: Heron Therapeutics announces acceptance of PAS application for dual-acting anesthetic